• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1976年至2018年明尼苏达州奥尔姆斯特德县胆管癌的发病率及长期预后

Incidence and Long-Term Outcomes of Biliary Tract Cancers in Olmsted County, Minnesota from 1976 to 2018.

作者信息

Nwankwo Eugene C, Guta Amerti, Cao Scarlett S, Yang Ju Dong, Abdalla Abubaker, Taha Wesam, Larson Joseph J, Yin Jun, Gores Gregory J, Cleary Sean P, Roberts Lewis R

机构信息

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.

Center for Clinical and Translational Science, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

Cancers (Basel). 2024 Jul 31;16(15):2720. doi: 10.3390/cancers16152720.

DOI:10.3390/cancers16152720
PMID:39123448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11311608/
Abstract

Biliary tract cancers, including cholangiocarcinoma, gallbladder, and ampulla of Vater cancers, rank second among hepatobiliary cancers, known for their poor prognoses. The United States has witnessed a notable increase in intrahepatic cholangiocarcinoma incidence. This study examines the incidence and survival outcomes of biliary tract cancers in Olmsted County, Minnesota from 1976 to 2018. Using data from the Rochester Epidemiology Project (REP), residents aged 20 and above were analyzed across four eras. Incidence rates were calculated and adjusted for age and sex, and temporal trends were assessed using Poisson regression. Intrahepatic cholangiocarcinoma exhibited a significant escalation in incidence rates over time, while gallbladder cancers showed a decline among women. Median survival times for biliary tract cancers notably improved. These findings confirm the rising incidence of intrahepatic cholangiocarcinoma and suggest improving survival rates. Nevertheless, the overall prognosis for biliary tract cancers remains very poor, emphasizing the continual need for enhanced management strategies and further research.

摘要

胆道癌,包括胆管癌、胆囊癌和壶腹癌,在肝胆癌中排名第二,预后较差。美国肝内胆管癌的发病率显著上升。本研究调查了1976年至2018年明尼苏达州奥尔姆斯特德县胆道癌的发病率和生存结果。利用罗切斯特流行病学项目(REP)的数据,对四个时期20岁及以上的居民进行了分析。计算发病率并根据年龄和性别进行调整,使用泊松回归评估时间趋势。肝内胆管癌的发病率随时间显著上升,而胆囊癌在女性中呈下降趋势。胆道癌的中位生存时间显著改善。这些发现证实了肝内胆管癌发病率的上升,并表明生存率有所提高。然而,胆道癌的总体预后仍然很差,强调持续需要加强管理策略和进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80fd/11311608/71f7e38a1a56/cancers-16-02720-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80fd/11311608/71f7e38a1a56/cancers-16-02720-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80fd/11311608/71f7e38a1a56/cancers-16-02720-g001.jpg

相似文献

1
Incidence and Long-Term Outcomes of Biliary Tract Cancers in Olmsted County, Minnesota from 1976 to 2018.1976年至2018年明尼苏达州奥尔姆斯特德县胆管癌的发病率及长期预后
Cancers (Basel). 2024 Jul 31;16(15):2720. doi: 10.3390/cancers16152720.
2
Biliary tract cancers in Olmsted County, Minnesota, 1976-2008.明尼苏达州奥姆斯特德县 1976-2008 年胆道癌。
Am J Gastroenterol. 2012 Aug;107(8):1256-62. doi: 10.1038/ajg.2012.173. Epub 2012 Jul 3.
3
Trends in the Mortality of Biliary Tract Cancers Based on Their Anatomical Site in the United States From 2009 to 2018.基于美国 2009 年至 2018 年解剖部位的胆道癌死亡率趋势。
Am J Gastroenterol. 2021 May 1;116(5):1053-1062. doi: 10.14309/ajg.0000000000001151.
4
Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013.美国胆道癌发病率和趋势按人口统计学分组,1999-2013 年。
Cancer. 2019 May 1;125(9):1489-1498. doi: 10.1002/cncr.31942. Epub 2019 Jan 15.
5
Epidemiologic patterns of biliary tract cancer in the United States: 2001-2015.美国胆道癌的流行病学模式:2001-2015 年。
BMC Cancer. 2022 Nov 16;22(1):1178. doi: 10.1186/s12885-022-10286-z.
6
Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database.2006 年至 2015 年韩国胆道癌的发病率和总生存率:利用国家健康信息数据库。
Gut Liver. 2019 Jan 15;13(1):104-113. doi: 10.5009/gnl18105.
7
The epidemiological trends of biliary tract cancers in the United States of America.美国胆道癌的流行病学趋势。
BMC Gastroenterol. 2022 Dec 29;22(1):546. doi: 10.1186/s12876-022-02637-8.
8
Biliary tract cancers have distinct epidemiological patterns and clinical characteristics according to tumour site.胆道癌根据肿瘤部位具有不同的流行病学模式和临床特征。
HPB (Oxford). 2023 Jun;25(6):693-703. doi: 10.1016/j.hpb.2023.02.016. Epub 2023 Feb 28.
9
Biliary tract malignancies: a population-based study on incidence, prognosis and management of patients.胆道恶性肿瘤:一项基于人群的患者发病率、预后及管理的研究
Scand J Gastroenterol. 2016 Dec;51(12):1520-1525. doi: 10.1080/00365521.2016.1218538. Epub 2016 Aug 24.
10
Biliary tract cancer incidence in the United States-Demographic and temporal variations by anatomic site.美国胆道癌发病率-按解剖部位划分的人口统计学和时间变化。
Int J Cancer. 2013 Oct 1;133(7):1664-71. doi: 10.1002/ijc.28161. Epub 2013 Apr 11.

引用本文的文献

1
Rising Incidence of Early-Onset Liver Cancer and Intrahepatic Bile Duct Cancer: Analysis of the National Childhood Cancer Registry Database.早发性肝癌和肝内胆管癌发病率上升:国家儿童癌症登记数据库分析
Cancers (Basel). 2025 Mar 28;17(7):1133. doi: 10.3390/cancers17071133.

本文引用的文献

1
Recent Advances in Systemic Therapy for Advanced Intrahepatic Cholangiocarcinoma.晚期肝内胆管癌全身治疗的最新进展
Liver Cancer. 2023 Jun 8;13(2):119-135. doi: 10.1159/000531458. eCollection 2024 Apr.
2
New trends in diagnosis and management of gallbladder carcinoma.胆囊癌诊断与治疗的新趋势
World J Gastrointest Oncol. 2024 Jan 15;16(1):13-29. doi: 10.4251/wjgo.v16.i1.13.
3
Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies.原发性硬化性胆管炎相关胆管癌:从发病机制到诊断与监测策略
Cancers (Basel). 2023 Oct 11;15(20):4947. doi: 10.3390/cancers15204947.
4
Epidemiology of cholangiocarcinoma.胆管癌的流行病学
Eur J Surg Oncol. 2025 Feb;51(2):107064. doi: 10.1016/j.ejso.2023.107064. Epub 2023 Sep 9.
5
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.帕博利珠单抗联合吉西他滨和顺铂与单纯吉西他滨和顺铂治疗晚期胆道癌患者的比较(KEYNOTE-966):一项随机、双盲、安慰剂对照、3 期临床试验。
Lancet. 2023 Jun 3;401(10391):1853-1865. doi: 10.1016/S0140-6736(23)00727-4. Epub 2023 Apr 16.
6
The epidemiological trends of biliary tract cancers in the United States of America.美国胆道癌的流行病学趋势。
BMC Gastroenterol. 2022 Dec 29;22(1):546. doi: 10.1186/s12876-022-02637-8.
7
Epidemiologic patterns of biliary tract cancer in the United States: 2001-2015.美国胆道癌的流行病学模式:2001-2015 年。
BMC Cancer. 2022 Nov 16;22(1):1178. doi: 10.1186/s12885-022-10286-z.
8
Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians.肝内胆管癌治疗进展:临床医生当前及未来治疗前景概述
CA Cancer J Clin. 2023 Mar;73(2):198-222. doi: 10.3322/caac.21759. Epub 2022 Oct 19.
9
Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017.美国 2001 至 2017 年胆管癌发病率和死亡率的时间变化。
Oncologist. 2022 Oct 1;27(10):874-883. doi: 10.1093/oncolo/oyac150.
10
Inflammatory pathways and cholangiocarcinoma risk mechanisms and prevention.炎症通路与胆管癌的风险机制及预防
Adv Cancer Res. 2022;156:39-73. doi: 10.1016/bs.acr.2022.02.001. Epub 2022 Mar 10.